Drugmaker Taro Rejects Sun Pharma's Latest Buyout Bid
Israel's Taro Pharmaceutical Industries Ltd. on Thursday shot down a $24.50-per-share cash offer from majority shareholder Sun Pharmaceutical Industries Ltd. to buy up the rest of the company, calling the unsolicited...To view the full article, register now.
Already a subscriber? Click here to view full article